EV Tax Credit Comes to an End & Why Trump Rx Will Not Fix High Drug Costs

Ed Elson is joined by Jon McNeill, CEO of DVx Ventures and board member at General Motors, to break down what the end of the EV tax credit means for the auto industry. He then turns to the Trump administration’s new website for buying prescription drugs directly from manufacturers, and explains why it may fall short of solving America’s high drug price problem. Courtney Breen, senior analyst at Bernstein Research, also joins Producer Claire Miller to break down who the real winners of TrumpRx will be.